Augnition Labs will be at the 2023 International Conference on Learning and Memory.

April 1, 2023 – Augnition Labs announced today that the company will be one of the featured sponsors at the 2023 International Conference on Learning and Memory (LEARNMEM™2023), which will be held on April 26-30 against the scenic backdrop of the surf and sand of Huntington Beach, California.

The University of California Irvine Center for the Neurobiology of Learning and Memory (CNLM) held the 1st International Conference on Learning and Memory (LEARNMEM™2018) in April 2018. It broadly covered numerous facets of the neuroscience of learning and memory with an emphasis on integrating across animal and human studies as well as across fundamental and translational science. It was held in celebration of the 35thAnniversary of the Center for the Neurobiology of Learning and Memory (CNLM) at UC Irvine. This 5-day conference featured plenary talks by distinguished neuroscientists, diverse and balanced symposia, short talks, and poster sessions. It also included innovative features such as a panel on open science and open publishing, in addition to a community engagement session in which young children critiqued work of renowned scientists in a live review (Frontiers for Young Minds). The conference was attended by more than 1,000 scientists from 35 different countries.

This month, the 2nd LEARNMEM conference will be held in celebration of the 40th Anniversary of the CNLM, which was established in 1983 by the UC Regents with James L. McGaugh as its Founding Director. Contributions from more than 700 scientists are featured across five days, including talks, posters, exhibits, workshops, and professional networking activities. Once again over 1,000 attendees from more than 30 countries around the world are registered to attend the conference in person.

Augnition Labs is proud to support such an interdisciplinary effort and company representatives are looking forward to connecting with learning and memory researchers in person during the conference.


Copyright © 2023 Augnition Labs, LLC.

Financial Compliance Information

Marco Peters, Ph.D.

Co-Founder and Scientific Advisor

Dr. Peters has over 20 years of experience in translational research, target discovery, and small molecule discovery for CNS indications. He built and managed small and large research teams, and his work has contributed to the discovery, progression, and clinical development of small molecule therapeutics for the treatment of multiple neurological indications including stroke, Alzheimer’s Disease, Parkinson’s disease, pain, and schizophrenia. He currently serves as vice president and head of translational science at Longboard Pharmaceuticals. Peters built the departments of Neurobiology and Behavioral Pharmacology, and managed target identification, in vivo pharmacology, and lead optimization at Dart Neuroscience. His work contributed to the advancement of multiple compounds into clinical development, and led to a broad intellectual property portfolio focused on enhancement of brain plasticity and cognitive function. Peters has a M.Sc. in Biochemistry from the Freie Universität Berlin, Germany and a PhD in Neuroscience from the University of London, UK. He conducted postdoctoral work on Alzheimer’s disease with Tetsuyuki Maruyama at Merck Sharp & Dohme (UK).